Previous experiences showed that biological therapies directly targeting IL‐6 receptor and TNF‐α have a significant effect on NETosis inhibition, which paralleled the reduction of disease activity and inflammatory mediators.12 Hence, we demonstrated a remarkable effect of B cell depletion on NETosis prevention, particularly in RA patients. The gene discussed is TNF; the disease is rheumatoid arthritis.